Introduction This is a follow-up to my first article in a continuing series where I will be identifying and presenting dividend growth stocks for an above-average long-term total return objective. My first article in this series covered AmerisourceBergen, a leading medical distributor that I presented as significantly undervalued. However, I offer this follow-up to illustrate Read more about McKesson Corp, Walgreens Boots Alliance, Cardinal Health Corp., CVS Health Corp: Medical Distributors an Industry on Sale[…]
Introduction As I stated in previous articles in this series, my primary objective is to provide the reader with a clear perspective of just how different individual stocks are and how different companies operating in different sectors are. Consequently, I will be covering every sector that FactSet covers. As different as each of these sectors Read more about Is There Real Value in These 7 Distribution Services Companies? Part 6[…]
Introduction As a value investor, I am totally cognizant of the reality that attractively valued bargains are hard to find in a strong bull market. Moreover, as an experienced value investor I clearly understand that low valuations in a raging bull market are usually associated with issues and challenges sometimes real, sometimes imaginary. The key Read more about Cardinal Health: A Dividend Aristocrat the Risk Is Already Priced In-Part 2 of 7[…]
Investing Thesis When investing for dividend growth there are several key attributes that I consider crucial for long-term success. My definition of long-term success is first and foremost to generate a steadily-rising dividend income stream, and secondarily, the opportunity to generate a reasonable level of capital appreciation. With this article I will present 12 dividend Read more about 12 Dividend Growth Stocks That Meet My “Magic Formula for Dividend Growth Investors”[…]
Finding attractively valued dividend growth stocks is getting harder and harder to do. The overall market has been on a relentless advance for many years now, and high quality dividend paying growth stocks have been leaders. Consequently, valuations have become extended beyond historical norms and I contend prudence. Nevertheless, there are attractive dividend growth stocks available if you’re willing to look hard enough.
As a value investor, I must admit to being very frustrated with the valuations I’m seeing on high-quality blue-chip dividend growth stocks. I have been vigorously searching for fairly valued dividend growth stocks to invest in. I have thoroughly screened and evaluated every company in the S&P Dividend Aristocrats, all three of the CCC (Champions, Contenders and Challengers) lists produced by David Fish, every dividend paying stock on the S&P 500, Fortune 500, NASDAQ 100, S&P 100 Large-cap, Dow Jones Industrial Average, and even the S&P 400 mid-cap universe.
Most everyone would agree that the stock market as measured by the S&P 500 is not cheap today. However, there might be a great deal of disagreement regarding precisely how overvalued the S&P 500 currently is. Nevertheless, I would agree that in the general sense, stocks are not exactly bargains today. This might especially be true regarding best-of-breed blue-chip dividend growth stocks. Low interest rates have enhanced the attraction for high-quality dividend paying stocks.
As the stock market continues its relentless advance, attractive valuations are getting harder and harder to find. This is especially true for the highest quality blue-chip dividend growth stocks. Perhaps more importantly, in addition to the market’s relentless advance, there has also been a clear flight to quality – especially with dividend growth stocks. Therefore, the vast majority of the best-of-breed blue-chip dividend paying stocks are currently trading at elevated levels. In other words, finding high quality and value is very rare today in the dividend growth segment.
These five above-average growing opportunities in the healthcare sector provide dividend growth investors potential alternatives to the traditional large-cap pharmaceuticals. This is a high quality group of healthcare companies that possess above-average growth potential plus an above-average dividend yield that is expected to grow at above-average future rates. Consequently, we believe these candidates offer the Read more about Five Healthy Dividend Growth Stocks to Cure What Ails Your Portfolio[…]
With interest rates hovering near all-time lows, investors needing income are faced with very limited choices. The traditional high yield available from bonds and other fixed income vehicles are no longer available to meet the needs of retirees needing income to live off. Moreover, it is almost a certainty that today’s low yields are not Read more about 42 Dividend Contenders for Above-Average Total Return[…]